- 如果您对该产品感兴趣的话，可以
- 产品名称：Dengue Virus VLP -Serotypes 1-4
- 产品型号：DENVX4VLP-100
- 产品展商：The Native Antigen Company
- 产品文档：无相关文档
- 发布时间：2024-05-07
- 在线询价
简单介绍
品牌：The Native Antigen Company
货号: DENVX4-VLP-100
品名：Dengue Virus VLP – Serotypes 1-4
Multi-pack of all Dengue Virus VLPs, containing 100ug each of VLPs from serotypes 1-4.
产品描述
|
产品介绍
|
|
品牌
|
The Native Antigen Company
|
|
货号
|
DENVX4-VLP-100
|
|
品名
|
Dengue Virus VLP - Serotypes 1-4
|
|
规格
|
4×100ug
|
|
描述
|
Multi-pack of all Dengue Virus VLPs, containing 100ug each of VLPs from serotypes 1-4
|
|
详情
|
VLPs are produced in human cell lines using state-of-the-art expression techniques.
Constructed from E, M and preM proteins, with secretion from the cell aided by substituting the C terminal 20% with the corresponding Japanese Encephalitis Virus sequence (all internal/transmembrane)
|
|
背景
|
Virus-Like Particles (VLPs) are an emerging vaccine technology. VLPs consist of protein shells comprising outer proteins specific to the virus in question. VLPs are more representative of how viral antigens are presented in vivo and while they are highly immunogenic they are non-infectious as they lack the core genetic material of the virus. Another important advantage of VLPs is that they more effectively activate key aspects of the immune response to achieve potent immune stimulation and to provide immunological memory. VLP-based vaccines have also shown to provide effective protection and are in current use for several diseases and in development for many others
|
- 温馨提示：为规避购买风险，建议您在购买前务必确认供应商资质与产品质量。
- 免责申明：以上内容为注册会员自行发布，若信息的真实性、合法性存在争议，平台将会监督协助处理，欢迎举报